Fetal Alcohol Spectrum Disorders Clinical Trial
Official title:
Families Moving Forward (FMF) Connect Pro for Mental Health Providers
Verified date | May 2024 |
Source | University of Rochester |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The goal of this clinical trial is to test a new provider-assisted version of the caregiver Families Moving Forward (FMF) Connect app ("FMF Connect Pro") with mental health providers in the United States. In FMF Connect Pro, mental health providers learn to do routine screening for prenatal alcohol exposure, diagnose fetal alcohol spectrum disorders (FASD), and support families in using the FMF Connect caregiver app. Two different training methods will be compared with a waitlist group in this study. The first training method involves 13-sessions of tele-mentoring using an Extension of Community Healthcare Outcomes (ECHO) approach. The second training method involves a self-directed approach in which providers will access similar content in any asynchronous format on a website. The main questions this study aims to answer are: - What is the proportion of agencies and providers who accept and participate in the clinical trial (Reach)? - Do study groups differ on provider outcome measures of Effectiveness (clients screened/diagnosed), Adoption (provider change in knowledge, self-efficacy), Implementation (practice change, FMF Connect Pro Dashboard usage), and Maintenance of FASD-informed care practice change? All mental health providers in the study will complete online assessments at study entry, 6 months, and 12 months.
Status | Recruiting |
Enrollment | 250 |
Est. completion date | April 30, 2027 |
Est. primary completion date | April 30, 2027 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: - Licensed mental health provider or supervised trainee - Employed by a community mental agency or in private practice - provides mental health services to children ages 3 to 12 or their families - provides services in the United States - Fluency in English - Access to the internet Exclusion Criteria: - Provides services outside of the United States - Does not provide mental health services to children ages 3 to 12 |
Country | Name | City | State |
---|---|---|---|
United States | Mt. Hope Family Center | Rochester | New York |
Lead Sponsor | Collaborator |
---|---|
University of Rochester | National Institute on Alcohol Abuse and Alcoholism (NIAAA) |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Reach: proportion of agencies who accept introductory webinar presentation | Research staff will document the number of mental health agencies who agree to participate in the introductory webinar presentation out of the total number approached. | 3 months prior to baseline | |
Primary | Reach: proportion of mental health providers who enroll in the study | Research staff will document the number of mental health providers who enroll in the study out of the total number of providers who attend the introductory webinar at recruitment. | 3 months prior to baseline | |
Primary | Reach: proportion of mental health providers who complete data collection | Research staff will document the number of mental health providers who complete follow-up data collection out of the total number of providers who enrolled in the study. | baseline to 6 months | |
Primary | Effectiveness: Percentage of clients screened for prenatal alcohol exposure | Mental health providers will be asked as part of the Practice Change survey at each time point the percentage of clients they screen for prenatal alcohol exposure. | baseline to 1 year | |
Primary | Effectiveness: Number of clients diagnosed with a fetal alcohol spectrum disorder | Mental health providers will be asked at each time point the number of clients they have diagnosed with a fetal alcohol spectrum disorder (using the DSM-5 Neurodevelopmental Disorder Associated with Prenatal Alcohol Exposure criteria). | baseline to 1 year | |
Primary | Effectiveness: Number of clients enrolled in FMF Connect Pro Dashboard | FMF Connect Pro Dashboard analytics will be examined to assess the number of clients providers have enrolled in FMF Connect. | baseline to 1 year | |
Primary | Adoption: Number of ECHO Sessions Completed | Participant attendance at each ECHO session will be measured for FMF Connect Pro with ECHO implementation group. There are 13 total sessions. | 6 months | |
Primary | Adoption: Number of Self-Directed Sessions Completed | Participant completion of each self-directed learning module will be measured for the FMF Connect Pro with Self-Directed implementation group. There are 13 total modules. | 6 months | |
Primary | Adoption: Change in Provider FASD-Informed Care Knowledge | Participant knowledge will be assessed using the Knowledge of FASD-Informed Care survey. This survey assesses the content and principles of FASD-informed care. The survey has 30 questions, with each question worth 1 point. Scores range from 0 to 30, with higher scores reflecting greater knowledge. | baseline to 6 months | |
Primary | Adoption: Change in FASD-Informed Care Self-Efficacy | Participant self-efficacy will be assessed using the FASD-Informed Care Self-Efficacy scale. This scale assesses provider self-efficacy in specific FASD- informed care skills in mental health settings. The measure includes 12 items. Items are rated on a 6-point Likert scale from 1 "no confidence" to 6 "highly confident/expert." Scores range from 12 to 72, with higher scores reflecting greater confidence or self-efficacy. | baseline to 6 months | |
Primary | Implementation: Change in FASD-informed practice | Participant practice change will be assessed using the FASD- Informed Care Practice Change scale. This measure is aligned with specific FASD-informed care behaviors taught in ECHO and self-directed versions of FMF Connect Pro. This measure includes 15 items rated on a 5-point scale, with scores ranging from 15 to 75. Higher scores reflect clinical practice more consistent with FASD-informed care. | baseline to 6 months | |
Primary | Maintenance: Change in FASD-informed practice | Participant practice change will be assessed using the FASD- Informed Care Practice Change scale. This measure is aligned with specific FASD-informed care behaviors taught in ECHO and self-directed versions of FMF Connect Pro. This measure includes 15 items rated on a 5-point scale, with scores ranging from 15 to 75. Higher scores reflect clinical practice more consistent with FASD-informed care. | 6 months to 1 year | |
Primary | Implementation and Maintenance: FMF Connect Pro Dashboard usage | FMF Connect Pro Dashboard analytics will be extracted to measure the number of times providers accessed the website. | baseline to 1 year | |
Secondary | Contextual determinants on outcomes: Mean score on the Theoretical Domains Framework (TDF) survey | Providers will complete an adapted version of the Theoretical Domains Framework (TDF) survey to assess possible barriers and facilitators impacting implementation of the intervention. The survey includes 27 items. Responses are scored from 1(strongly disagree) to 7 (strongly agree). Scores range from 27 to 189, with higher scores reflecting greater agreement. | baseline to 1 year |
Status | Clinical Trial | Phase | |
---|---|---|---|
Not yet recruiting |
NCT06163651 -
Evaluating a One-Year Version of the Parent-Child Assistance Program
|
N/A | |
Completed |
NCT01961050 -
Preventing FAS/ARND in Russian Children
|
N/A | |
Recruiting |
NCT05108974 -
Choline Supplementation as a Neurodevelopmental Intervention in Fetal Alcohol Spectrum Disorders Study
|
Phase 2 | |
Completed |
NCT02457676 -
Improving Self Regulation in Children With Fetal Alcohol Syndrome Spectrum Disorders: A Neuroplastic Intervention
|
N/A | |
Recruiting |
NCT06005181 -
The Synchrony Study: Examining Music Training for Children With FASD
|
N/A | |
Completed |
NCT04571463 -
Ethyl Glucuronide in Urine Samples of Pregnant Women Within the HUS ja PHHYKY Area
|
||
Completed |
NCT03361293 -
Cognitive Training and tDCS for Children With FASD
|
N/A | |
Recruiting |
NCT05534568 -
The Oklahoma Parent-Child Assistance Program
|
N/A | |
Recruiting |
NCT05456321 -
CIFASD 5 tDCS and Cognitive Training
|
N/A | |
Completed |
NCT01911299 -
Choline Supplementation in Children With Fetal Alcohol Spectrum Disorders
|
Phase 2 | |
Recruiting |
NCT04332172 -
Scaling Up: A Multi-Site Trial of e-SBI for Alcohol Use in Pregnancy
|
N/A | |
Completed |
NCT05604014 -
Feasibility Study of the My Health Coach App for Adults With FASD
|
N/A | |
Terminated |
NCT03852550 -
READYorNot[TM] Brain-Based Disabilities Trial
|
N/A | |
Completed |
NCT02735473 -
Choline Supplementation as a Neurodevelopmental Intervention in Fetal Alcohol Spectrum Disorders
|
Phase 2 | |
Completed |
NCT03782935 -
Nutritional Risk Factors for FASD in Ukraine
|
N/A | |
Not yet recruiting |
NCT04918043 -
Alcohol Use During Pregnancy in Finland According to Meconium Samples
|
||
Completed |
NCT04072809 -
Dissecting the Genetics of Fetal Alcohol Spectrum Disorders
|
||
Completed |
NCT01149538 -
Postnatal Choline Supplementation in Children With Prenatal Alcohol Exposure
|
Phase 1/Phase 2 | |
Completed |
NCT05028517 -
Efficacy Trial of the FMF Connect Mobile Health Intervention
|
N/A | |
Completed |
NCT04194489 -
Trial of the Families Moving Forward (FMF) Connect Mobile Health Intervention
|
N/A |